health · HHS-HRSA
Hereditary Hemorrhagic Telangiectasia (HHT) Center
Health Resources and Services Administration · HRSA-26-092
Award Range
$0 – $2.9M
Total Program Funding
$2.9M
Expected Awards
1
Deadline
July 10, 2026
GRANTQUICK SUMMARYPlain-English Overview
Hereditary Hemorrhagic Telangiectasia (HHT) Center. Health Resources and Services Administration. The purpose of the Hereditary Hemorrhagic Telangiectasia (HHT) Center Program is to reduce illness and death related to HHT by partnering with clinical center to expand access and coordination of care; creating innovative strategies that support clinicians with identifying and diagnosing HHT cases;... up to $2,900,000 per award; $2,900,000 total program funding; ~1 awards expected.
Who Should Apply
State governments, Unrestricted (any eligible entity)
Who Should NOT Apply
Few restrictions — most eligible entities can apply
Key Requirements (Plain English)
- •"Domestic" means the 50 states, the District of Columbia, the Commonwealth of Puerto Rico, the Northern Mariana Islands, American Samoa, Guam, the U
- •Deadline: 2026-07-10
💡 GrantQuick Tip
High-value award — invest significantly in proposal quality. Consider hiring a grant writer.
Competitiveness: Very high — extremely limited awards available
What This Grant Funds
Attachments
Who Can Apply
Eligible Applicant Types
Funding Details
- Maximum Award
- $2.9M
- Total Program Funding
- $2.9M
- Expected Number of Awards
- 1
- Cost Sharing Required?
- No
- Funding Instrument
- cooperative_agreement
Key Dates
Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Agency Contact
Nordia Williams nwilliams1@hrsa.gov
nwilliams1@hrsa.govReady to apply?
View the full NOFO and submit your application on Grants.gov